-
Primary Interviews and Information Gathering Process 3.4.2. Breakdown of Primary
-
Respondents 3.5. Forecasting Model 3.6. Market Size Estimation 3.6.1. Bottom-Up
-
Approach 3.6.2. Top-Down Approach 3.7. Data Triangulation 3.8. Validation 4. MARKET
-
DYNAMICS 4.1. Overview 4.2. Drivers 4.3. Restraints 4.4. Opportunities 5. MARKET FACTOR ANALYSIS 5.1. Value chain Analysis 5.2. Porter's Five Forces Analysis 5.2.1.
-
Bargaining Power of Suppliers 5.2.2. Bargaining Power of Buyers 5.2.3. Threat of
-
New Entrants 5.2.4. Threat of Substitutes 5.2.5. Intensity of Rivalry 5.3. COVID-19
-
Impact Analysis 5.3.1. Market Impact Analysis 5.3.2. Regional Impact 5.3.3. Opportunity
-
and Threat Analysis 6. SOUTH AMERICA MICROBIOME SEQUENCING SERVICES MARKET, BY TECHNOLOGY
-
(USD MILLION) 6.1. Sequencing by Litigation (SBL) 6.2. Sequencing by Synthesis (SBS)
-
Short Gun Sequencing 6.4. Targeted Gene Sequencing 6.5. RNA Sequencing 6.6.
-
Others 7. SOUTH AMERICA MICROBIOME SEQUENCING SERVICES MARKET, BY APPLICATION (USD
-
MILLION) 7.1. Gastrointestinal Diseases 7.2. Infectious Diseases 7.3. CNS Diseases
-
Oncology 7.5. Others 8. SOUTH AMERICA MICROBIOME SEQUENCING SERVICES MARKET,
-
BY REGIONAL (USD MILLION) 8.1. Brazil 8.2. Mexico 8.3. Argentina 8.4. Rest of South
-
America 9. COMPETITIVE LANDSCAPE 9.1. Overview 9.2. Competitive Analysis 9.3. Market
-
share Analysis 9.4. Major Growth Strategy in the Microbiome Sequencing Services
-
Market 9.5. Competitive Benchmarking 9.6. Leading Players in Terms of Number of
-
Developments in the Microbiome Sequencing Services Market 9.7. Key developments
-
and growth strategies 9.7.1. New Product Launch/Service Deployment 9.7.2. Merger
-
& Acquisitions 9.7.3. Joint Ventures 9.8. Major Players Financial Matrix 9.8.1.
-
Sales and Operating Income 9.8.2. Major Players R&D Expenditure. 2023 10. COMPANY
-
PROFILES 10.1. Zymo Research 10.1.1. Financial Overview 10.1.2. Products Offered
-
Key Developments 10.1.4. SWOT Analysis 10.1.5. Key Strategies 10.2. Element
-
Biosciences 10.2.1. Financial Overview 10.2.2. Products Offered 10.2.3. Key Developments
-
SWOT Analysis 10.2.5. Key Strategies 10.3. BioRad Laboratories 10.3.1. Financial
-
Overview 10.3.2. Products Offered 10.3.3. Key Developments 10.3.4. SWOT Analysis
-
Key Strategies 10.4. Genscript 10.4.1. Financial Overview 10.4.2. Products
-
Offered 10.4.3. Key Developments 10.4.4. SWOT Analysis 10.4.5. Key Strategies 10.5.
-
Genomatix Software 10.5.1. Financial Overview 10.5.2. Products Offered 10.5.3. Key
-
Developments 10.5.4. SWOT Analysis 10.5.5. Key Strategies 10.6. Qiagen 10.6.1. Financial
-
Overview 10.6.2. Products Offered 10.6.3. Key Developments 10.6.4. SWOT Analysis
-
Key Strategies 10.7. Thermo Fisher Scientific 10.7.1. Financial Overview
- Products Offered 10.7.3. Key Developments 10.7.4. SWOT Analysis 10.7.5.
-
Key Strategies 10.8. Illumina 10.8.1. Financial Overview 10.8.2. Products Offered
-
Key Developments 10.8.4. SWOT Analysis 10.8.5. Key Strategies 10.9. Agilent
-
Technologies 10.9.1. Financial Overview 10.9.2. Products Offered 10.9.3. Key Developments
-
SWOT Analysis 10.9.5. Key Strategies 10.10. Novogene 10.10.1. Financial
-
Overview 10.10.2. Products Offered 10.10.3. Key Developments 10.10.4. SWOT Analysis
-
Key Strategies 10.11. Oxford Nanopore Technologies 10.11.1. Financial Overview
- Products Offered 10.11.3. Key Developments 10.11.4. SWOT Analysis 10.11.5.
-
Key Strategies 10.12. Merck KGaA 10.12.1. Financial Overview 10.12.2. Products Offered
-
Key Developments 10.12.4. SWOT Analysis 10.12.5. Key Strategies 10.13.
-
BGI Genomics 10.13.1. Financial Overview 10.13.2. Products Offered 10.13.3. Key
-
Developments 10.13.4. SWOT Analysis 10.13.5. Key Strategies 10.14. PacBio 10.14.1.
-
Financial Overview 10.14.2. Products Offered 10.14.3. Key Developments 10.14.4.
-
SWOT Analysis 10.14.5. Key Strategies 10.15. Pierian Dx 10.15.1. Financial Overview
-
Products Offered 10.15.3. Key Developments 10.15.4. SWOT Analysis 10.15.5.
-
Key Strategies 11. APPENDIX 11.1. References 11.2. Related Reports LIST OF TABLESTABLE
-
LIST OF ASSUMPTIONS TABLE 2. SOUTH AMERICA MICROBIOME SEQUENCING SERVICES MARKET
-
SIZE ESTIMATES & FORECAST, BY TECHNOLOGY, 2019-2035 (USD BILLIONS) TABLE 3.
-
SOUTH AMERICA MICROBIOME SEQUENCING SERVICES MARKET SIZE ESTIMATES & FORECAST,
-
BY APPLICATION, 2019-2035 (USD BILLIONS) TABLE 4. SOUTH AMERICA MICROBIOME SEQUENCING
-
SERVICES MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
-
SERVICES MARKET ANALYSIS BY TECHNOLOGY FIGURE 3. SOUTH AMERICA MICROBIOME SEQUENCING
-
SERVICES MARKET ANALYSIS BY APPLICATION FIGURE 4. SOUTH AMERICA MICROBIOME SEQUENCING
-
SERVICES MARKET ANALYSIS BY REGIONAL FIGURE 5. KEY BUYING CRITERIA OF MICROBIOME
-
SEQUENCING SERVICES MARKET FIGURE 6. RESEARCH PROCESS OF MRFR FIGURE 7. DRO ANALYSIS
-
OF MICROBIOME SEQUENCING SERVICES MARKET FIGURE 8. DRIVERS IMPACT ANALYSIS: MICROBIOME
-
SEQUENCING SERVICES MARKET FIGURE 9. RESTRAINTS IMPACT ANALYSIS: MICROBIOME SEQUENCING
-
SERVICES MARKET FIGURE 10. SUPPLY / VALUE CHAIN: MICROBIOME SEQUENCING SERVICES
-
MARKET FIGURE 11. MICROBIOME SEQUENCING SERVICES MARKET, BY TECHNOLOGY, 2025 (%
-
SHARE) FIGURE 12. MICROBIOME SEQUENCING SERVICES MARKET, BY TECHNOLOGY, 2019 TO
-
(USD Billions) FIGURE 13. MICROBIOME SEQUENCING SERVICES MARKET, BY APPLICATION,
-
(% SHARE) FIGURE 14. MICROBIOME SEQUENCING SERVICES MARKET, BY APPLICATION,
-
TO 2035 (USD Billions) FIGURE 15. MICROBIOME SEQUENCING SERVICES MARKET, BY
-
REGIONAL, 2025 (% SHARE) FIGURE 16. MICROBIOME SEQUENCING SERVICES MARKET, BY REGIONAL,
-
TO 2035 (USD Billions) FIGURE 17. BENCHMARKING OF MAJOR COMPETITORS